Pharmacokinetics and Biodistribution of Phages and their Current Applications in Antimicrobial Therapy
Abstract: Antimicrobial resistance remains a critical global health concern, necessitating the investigation of alternative therapeutic approaches. With the diminished efficacy of conventional small molecule drugs due to the emergence of highly resilient bacterial strains, there is growing interest in the potential for alternative therapeutic modalities. As naturally occurring viruses of bacteria, bacteriophage (or phage) are being re‐envisioned as a platform to engineer properties that can be tailored to target specific bacterial strains and employ diverse antibacterial mechanisms. However, limited understanding of key pharmacological properties of phage is a major challenge to translating its use from preclinical to clinical settings. Here, this work reviews modern advancements in phage‐based antimicrobial therapy and discusses the in vivo pharmacokinetics and biodistribution of phage, addressing critical challenges in their application that must be overcome for successful clinical implementation.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Pharmacokinetics and Biodistribution of Phages and their Current Applications in Antimicrobial Therapy ; day:22 ; month:12 ; year:2023 ; extent:11
Advanced therapeutics ; (22.12.2023) (gesamt 11)
- Creator
-
Kang, Dayeon
Bagchi, Damayanti
Chen, Irene A.
- DOI
-
10.1002/adtp.202300355
- URN
-
urn:nbn:de:101:1-2023122314242863856641
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kang, Dayeon
- Bagchi, Damayanti
- Chen, Irene A.
Other Objects (12)
Improving the pharmacokinetics, biodistribution and plasma stability of monobodies
Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides
Studies on biodistribution and pharmacokinetics of capsid-modified adenoviral vectors
Pharmacokinetics and biodistribution of negatively charged pectin nanoparticles encapsulating paclitaxel
Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo
In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Antimicrobial Peptides
Intravitreal Administration of Adalimumab‐Loaded Poly (Lactic‐co‐Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics
Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide
Pharmacokinetics of antimicrobial agents : principles, methods, application
Improving the pharmacokinetics, biodistribution and plasma stability of monobodies
Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides
Studies on biodistribution and pharmacokinetics of capsid-modified adenoviral vectors
Pharmacokinetics and biodistribution of negatively charged pectin nanoparticles encapsulating paclitaxel
Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo
In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Antimicrobial Peptides
Intravitreal Administration of Adalimumab‐Loaded Poly (Lactic‐co‐Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics
Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide
Pharmacokinetics of antimicrobial agents : principles, methods, application
Improving the pharmacokinetics, biodistribution and plasma stability of monobodies
Pharmacokinetics, biodistribution and toxicology of novel cell-penetrating peptides
Studies on biodistribution and pharmacokinetics of capsid-modified adenoviral vectors
Pharmacokinetics and biodistribution of negatively charged pectin nanoparticles encapsulating paclitaxel
Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy
Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model
Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo
In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Antimicrobial Peptides
Intravitreal Administration of Adalimumab‐Loaded Poly (Lactic‐co‐Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics
Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide